Search
for

    Sort by

    Research 481–510 of 1000+

    1. A histological study of the effect of panax ginseng versus finasteride on induced benign prostatic hyperplasia in rats with potentiality of spontaneous recovery The Egyptian Journal of Histology · 2020 · 1 citations
    2. Effect of a Benign Prostatic Hyperplasia (BPH) Xenobiotic - Croton membranaceus Müll.Arg. Root Extract on CYP1A2, CYP3A4, CYP2D6, and GSTM1 Drug Metabolizing Enzymes in Rat Model 2020 · 1 citations
    3. Asociación entre disfunción eréctil y funcionalidad del subsistema conyugal en pacientes con hiperplasia prostática benigna REMUS - Revista Estudiantil de Medicina de la Universidad de Sonora · 2020 · 1 citations
    4. The relation between androgenetic thin hair diagnosed by trichoscope and benign prostatic hyperplasia Journal of Cosmetic Dermatology · 2018 · 1 citations
    5. Acción de Finasteride sobre el volumen prostático en caninos con hiperplasia prostática benigna El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · 2002 · 1 citations
    6. Benign Prostatic Hyperplasia Pharmacotherapy and Incident Ocular Surface Disease: Comparative Risk of Alpha-Blockers vs 5-Alpha Reductase Inhibitors Urology · 2026
    7. Modulation of AR-FGF-2-TGF beta Axis by Cosmos caudatus Suppresses Prostatic Epithelial Proliferation in a BPH Rat Model: A Comparative Study with Finasteride Journal of Multidisciplinary Applied Natural Science · 2026
    8. Low-dose finasteride in benign prostatic hyperplasia: a comprehensive narrative review of efficacy, safety, and preventative potential Translational Andrology and Urology · 2026
    9. Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia Zenodo (CERN European Organization for Nuclear Research) · 2026
    10. Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia Zenodo (CERN European Organization for Nuclear Research) · 2026
    11. Adverse effects of finasteride in men treated for benign prostatic hyperplasia and androgenetic alopecia - a literature review Journal of Education Health and Sport · 2025
    12. Efficacy, safety, and adverse effects of finasteride and dutasteride in treating benign prostatic hyperplasia: A retrospective cohort study Zanco Journal of Medical Sciences · 2024
    13. Re: The risk of psychiatric disorders in finasteride users with benign prostatic hyperplasia (BPH) and androgenetic alopecia (AGA): A population‐based case–control study Australasian Journal of Dermatology · 2024
    14. Androgenic Alopecia Is Associated With More Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia LUTS Lower Urinary Tract Symptoms · 2024
    15. The risk of psychiatric disorders in finasteride users with benign prostatic hyperplasia and androgenetic alopecia: A population‐based case–control study Australasian Journal of Dermatology · 2024
    16. The Association of Male Pattern Baldness in Men with Benign Prostatic Hyperplasia Jordan Medical Journal · 2023
    17. Re: Long-Term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial The Journal of Urology · 2017
    18. Konvergentna validacija farmakoekonomskih aspekata terapije benigne hiperplazije prostate u Crnoj Gori National Repository of Dissertations in Serbia · 2016
    19. Re: Associations Between Variants in the Cyclooxygenase 2 Enzyme Gene (PTGS2) and Development of Benign Prostate Enlargement The Journal of Urology · 2012
    20. Efecto en el sangrado perioperatorio durante la resección transuretral de la próstata tras un mes de tratamiento con dutasteride Actas Urológicas Españolas · 2010
    21. IMPACT OF LOW DOSE FINASTERIDE FOR THE TREATMENT OF ANDROGENIC ALOPECIA ON SERUM PROSTATE SPECIFIC ANTIGEN (PSA) LEVELS IN MEN PARTICIPATED IN POPULATION-BASED SCREENING FOR PROSTATE CANCER The Journal of Urology · 2009
    22. PREVALENCIA DE APEGO AL TRATAMIENTO CON FINASTERIDA EN PACIENTES CON HIPERPLASIA BENIGNA DE PRÓSTATA DE UN SERVICIO DE UROLOGÍA DEL I.S.S.S.T.E. 2008
    23. Dutasteride: a guide to its use as monotherapy in benign prostatic hyperplasia Drugs & therapy perspectives · 2008
    24. Tratamientos fitoterapeúticos para la hipertrofia benigna de próstata: serenoa repens Metas de Enfermería · 2005
    25. La combinación de finasteride y doxazosina fue más efectiva que la monoterapia en la hiperplasia prostática benigna Evidencia actualizacion en la práctica ambulatoria · 2004
    26. The prognostic value of androgenetic alopecia and benign prostatic hyperplasia in men with COVID-19: a prospective multidisciplinaryobservational study of 766 patients from Turkey Journal of health sciences and medicine · 2022
    27. SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients Frontiers in Immunology · 2022
    28. Association of Androgenetic Alopecia with Benign Prostatic Hyperplasia: A Case Control Study Nepal journal of dermatology, venereology & leprology · 2018
    29. The E211 G>A Androgen Receptor Polymorphism Is Associated with a Decreased Risk of Metastatic Prostate Cancer and Androgenetic Alopecia Cancer Epidemiology, Biomarkers & Prevention · 2005 · 76 citations
    30. Relationship Between Male Pattern Baldness and the Risk of Aggressive Prostate Cancer: An Analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Journal of Clinical Oncology · 2014 · 28 citations